Capital International Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-967,357
| Closed | -$44.6M | – | 449 |
|
|
2023
Q2 | $44.6M | Sell |
967,357
-327,203
| -25% | -$15.2M | 0.01% | 342 |
|
|
2023
Q1 | $51.9M | Hold |
1,294,560
| – | – | 0.01% | 333 |
|
|
2022
Q4 | $60M | Sell |
1,294,560
-2,096,522
| -62% | -$82.5M | 0.02% | 318 |
|
|
2022
Q3 | $140M | Sell |
3,391,082
-21,324
| -0.6% | -$1.1M | 0.04% | 263 |
|
|
2022
Q2 | $204M | Buy |
3,412,406
+67,380
| +2% | +$4.15M | 0.06% | 244 |
|
|
2022
Q1 | $243M | Sell |
3,345,026
-2,024,748
| -38% | -$141M | 0.06% | 242 |
|
|
2021
Q4 | $452M | Sell |
5,369,774
-295,419
| -5% | -$24M | 0.1% | 186 |
|
|
2021
Q3 | $511M | Buy |
5,665,193
+208,069
| +4% | +$18.8M | 0.12% | 168 |
|
|
2021
Q2 | $520M | Buy |
5,457,124
+33,002
| +0.6% | +$3.44M | 0.12% | 168 |
|
|
2021
Q1 | $618M | Sell |
5,424,122
-837,184
| -13% | -$114M | 0.16% | 140 |
|
|
2020
Q4 | $867M | Buy |
6,261,306
+63,357
| +1% | +$7.52M | 0.24% | 114 |
|
|
2020
Q3 | $509M | Buy |
6,197,949
+112,817
| +2% | +$9.35M | 0.16% | 134 |
|
|
2020
Q2 | $476M | Sell |
6,085,132
-47,062
| -0.8% | -$3.12M | 0.16% | 131 |
|
|
2020
Q1 | $272M | Buy |
6,132,194
+89,619
| +1% | +$4.65M | 0.11% | 148 |
|
|
2019
Q4 | $258M | Buy |
6,042,575
+33,818
| +0.6% | +$1.4M | 0.09% | 168 |
|
|
2019
Q3 | $257M | Buy |
6,008,757
+390,195
| +7% | +$21.2M | 0.1% | 165 |
|
|
2019
Q2 | $357M | Buy |
5,618,562
+50,013
| +0.9% | +$3.18M | 0.14% | 148 |
|
|
2019
Q1 | $386M | Buy |
5,568,549
+978,695
| +21% | +$55.9M | 0.17% | 138 |
|
|
2018
Q4 | $200M | Buy |
4,589,854
+229,963
| +5% | +$12.6M | 0.1% | 167 |
|
|
2018
Q3 | $333M | Buy |
4,359,891
+755,127
| +21% | +$61.4M | 0.15% | 150 |
|
|
2018
Q2 | $277M | Buy |
3,604,764
+13,718
| +0.4% | +$886K | 0.31% | 105 |
|
|
2018
Q1 | $183M | Buy |
3,591,046
+12,259
| +0.3% | +$617K | 0.21% | 121 |
|
|
2017
Q4 | $166M | Buy |
3,578,787
+683,306
| +24% | +$33.5M | 0.19% | 127 |
|
|
2017
Q3 | $154M | Buy |
2,895,481
+520,496
| +22% | +$30.8M | 0.18% | 137 |
|
|
2017
Q2 | $148M | Buy |
2,374,985
+198,252
| +9% | +$11.9M | 0.2% | 133 |
|
|
2017
Q1 | $148M | Buy |
2,176,733
+1,175,879
| +117% | +$89.6M | 0.2% | 131 |
|
|
2016
Q4 | $70.4M | Buy |
1,000,854
+520,554
| +108% | +$36.9M | 0.1% | 170 |
|
|
2016
Q3 | $34.1M | Buy |
+480,300
| New | +$30.7M | 0.05% | 215 |
|
Other funds holding RARE
RI
